Selected research
Industry Research
Pets Anti-infective Drugs Industry Research Report 2026
Market perspective
The global Pets Anti-infective Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pets Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pets Anti-infective Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pets Anti-infective Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pets Anti-infective Drugs include Bimeda Animal Health, Ceva Santé Animale, Dechra Veterinary Products, Elanco, Norbrook, Ouro Fino Saude, Vetoquinol, Virbac and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pets Anti-infective Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pets Anti-infective Drugs Market by Company
Bimeda Animal Health
Ceva Santé Animale
Dechra Veterinary Products
Elanco
Norbrook
Ouro Fino Saude
Vetoquinol
Virbac
Zoetis
Zhejiang Hisun Animal Healthcare Products
Hanvet Pet Health
Wuhan Hvsen Biotechnology
Nanjing Jindun Animal
Merck
Wuhan Chopperlvya
Pets Anti-infective Drugs Segment by Type
Injection
External Use
Internal Use
Pets Anti-infective Drugs Segment by Application
Dog
Cat
Others
Pets Anti-infective Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pets Anti-infective Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pets Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- External Use
- Internal Use
Applications
- Dog
- Cat
- Others
Companies covered
- Bimeda Animal Health
- Ceva Santé Animale
- Dechra Veterinary Products
- Elanco
- Norbrook
- Ouro Fino Saude
- Vetoquinol
- Virbac
- Zoetis
- Zhejiang Hisun Animal Healthcare Products
- Hanvet Pet Health
- Wuhan Hvsen Biotechnology
- Nanjing Jindun Animal
- Merck
- Wuhan Chopperlvya
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pets Anti-infective Drugs Market Size (2021-2032)
- 2.2.2 Global Pets Anti-infective Drugs Sales (2021-2032)
- 2.2.3 Global Pets Anti-infective Drugs Market Average Price (2021-2032)
- 2.3 Pets Anti-infective Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 External Use
- 2.3.4 Internal Use
- 2.4 Pets Anti-infective Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dog
- 2.4.3 Cat
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pets Anti-infective Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pets Anti-infective Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pets Anti-infective Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Pets Anti-infective Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Pets Anti-infective Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pets Anti-infective Drugs, Product Type & Application
- 3.8 Global Manufacturers of Pets Anti-infective Drugs, Established Date
- 3.9 Global Pets Anti-infective Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bimeda Animal Health
- 4.1.1 Bimeda Animal Health Company Information
- 4.1.2 Bimeda Animal Health Business Overview
- 4.1.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
- 4.1.5 Bimeda Animal Health Recent Developments
- 4.2 Ceva Santé Animale
- 4.2.1 Ceva Santé Animale Company Information
- 4.2.2 Ceva Santé Animale Business Overview
- 4.2.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
- 4.2.5 Ceva Santé Animale Recent Developments
- 4.3 Dechra Veterinary Products
- 4.3.1 Dechra Veterinary Products Company Information
- 4.3.2 Dechra Veterinary Products Business Overview
- 4.3.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
- 4.3.5 Dechra Veterinary Products Recent Developments
- 4.4 Elanco
- 4.4.1 Elanco Company Information
- 4.4.2 Elanco Business Overview
- 4.4.3 Elanco Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Elanco Pets Anti-infective Drugs Product Portfolio
- 4.4.5 Elanco Recent Developments
- 4.5 Norbrook
- 4.5.1 Norbrook Company Information
- 4.5.2 Norbrook Business Overview
- 4.5.3 Norbrook Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Norbrook Pets Anti-infective Drugs Product Portfolio
- 4.5.5 Norbrook Recent Developments
- 4.6 Ouro Fino Saude
- 4.6.1 Ouro Fino Saude Company Information
- 4.6.2 Ouro Fino Saude Business Overview
- 4.6.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
- 4.6.5 Ouro Fino Saude Recent Developments
- 4.7 Vetoquinol
- 4.7.1 Vetoquinol Company Information
- 4.7.2 Vetoquinol Business Overview
- 4.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
- 4.7.5 Vetoquinol Recent Developments
- 4.8 Virbac
- 4.8.1 Virbac Company Information
- 4.8.2 Virbac Business Overview
- 4.8.3 Virbac Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Virbac Pets Anti-infective Drugs Product Portfolio
- 4.8.5 Virbac Recent Developments
- 4.9 Zoetis
- 4.9.1 Zoetis Company Information
- 4.9.2 Zoetis Business Overview
- 4.9.3 Zoetis Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zoetis Pets Anti-infective Drugs Product Portfolio
- 4.9.5 Zoetis Recent Developments
- 4.10 Zhejiang Hisun Animal Healthcare Products
- 4.10.1 Zhejiang Hisun Animal Healthcare Products Company Information
- 4.10.2 Zhejiang Hisun Animal Healthcare Products Business Overview
- 4.10.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio
- 4.10.5 Zhejiang Hisun Animal Healthcare Products Recent Developments
- 4.11 Hanvet Pet Health
- 4.11.1 Hanvet Pet Health Company Information
- 4.11.2 Hanvet Pet Health Business Overview
- 4.11.3 Hanvet Pet Health Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio
- 4.11.5 Hanvet Pet Health Recent Developments
- 4.12 Wuhan Hvsen Biotechnology
- 4.12.1 Wuhan Hvsen Biotechnology Company Information
- 4.12.2 Wuhan Hvsen Biotechnology Business Overview
- 4.12.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio
- 4.12.5 Wuhan Hvsen Biotechnology Recent Developments
- 4.13 Nanjing Jindun Animal
- 4.13.1 Nanjing Jindun Animal Company Information
- 4.13.2 Nanjing Jindun Animal Business Overview
- 4.13.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
- 4.13.5 Nanjing Jindun Animal Recent Developments
- 4.14 Merck
- 4.14.1 Merck Company Information
- 4.14.2 Merck Business Overview
- 4.14.3 Merck Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Merck Pets Anti-infective Drugs Product Portfolio
- 4.14.5 Merck Recent Developments
- 4.15 Wuhan Chopperlvya
- 4.15.1 Wuhan Chopperlvya Company Information
- 4.15.2 Wuhan Chopperlvya Business Overview
- 4.15.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
- 4.15.5 Wuhan Chopperlvya Recent Developments
5 Global Pets Anti-infective Drugs Market Scenario by Region
- 5.1 Global Pets Anti-infective Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pets Anti-infective Drugs Sales by Region: 2021-2032
- 5.2.1 Global Pets Anti-infective Drugs Sales by Region: 2021-2026
- 5.2.2 Global Pets Anti-infective Drugs Sales by Region: 2027-2032
- 5.3 Global Pets Anti-infective Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Pets Anti-infective Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Pets Anti-infective Drugs Revenue by Region: 2027-2032
- 5.4 North America Pets Anti-infective Drugs Market Facts & Figures by Country
- 5.4.1 North America Pets Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pets Anti-infective Drugs Sales by Country (2021-2032)
- 5.4.3 North America Pets Anti-infective Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pets Anti-infective Drugs Market Facts & Figures by Country
- 5.5.1 Europe Pets Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pets Anti-infective Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Pets Anti-infective Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Pets Anti-infective Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pets Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pets Anti-infective Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pets Anti-infective Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pets Anti-infective Drugs Market Facts & Figures by Country
- 5.7.1 South America Pets Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pets Anti-infective Drugs Sales by Country (2021-2032)
- 5.7.3 South America Pets Anti-infective Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pets Anti-infective Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pets Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pets Anti-infective Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pets Anti-infective Drugs Sales by Type (2021-2032)
- 6.1.1 Global Pets Anti-infective Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Pets Anti-infective Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Pets Anti-infective Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Pets Anti-infective Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pets Anti-infective Drugs Sales by Application (2021-2032)
- 7.1.1 Global Pets Anti-infective Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Pets Anti-infective Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Pets Anti-infective Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Pets Anti-infective Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pets Anti-infective Drugs Value Chain Analysis
- 8.1.1 Pets Anti-infective Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pets Anti-infective Drugs Production Mode & Process
- 8.2 Pets Anti-infective Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pets Anti-infective Drugs Distributors
- 8.2.3 Pets Anti-infective Drugs Customers
9 Global Pets Anti-infective Drugs Analyzing Market Dynamics
- 9.1 Pets Anti-infective Drugs Industry Trends
- 9.2 Pets Anti-infective Drugs Industry Drivers
- 9.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
- 9.4 Pets Anti-infective Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst